These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 11825477)

  • 61. Relationship between Lens culinaris agglutinin-reactive alpha-fetoprotein and pathologic features of hepatocellular carcinoma.
    Tada T; Kumada T; Toyoda H; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kitabatake S; Kuzuya T; Nonogaki K; Shimizu J; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J; Satomura S
    Liver Int; 2005 Aug; 25(4):848-53. PubMed ID: 15998436
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Quantitation of alpha-fetoprotein messenger RNA in peripheral blood of nude mice and its relationship with tumor recurrence and metastasis after curative resection of hepatocellular carcinoma].
    Wu X; Lin Z; Fan J; Lu J; Wang L; Tang Z
    Zhonghua Gan Zang Bing Za Zhi; 2002 Jun; 10(3):189-91. PubMed ID: 12113675
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Single nucleotide polymorphism in the promoter region of human alpha-fetoprotein (AFP) gene and its significance in hepatocellular carcinoma (HCC).
    Chen GG; Ho RL; Wong J; Lee KF; Lai PB
    Eur J Surg Oncol; 2007 Sep; 33(7):882-6. PubMed ID: 17433605
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Genetic detection and clinical applications in patients with hepatocellular carcinoma].
    Takeda S; Nakao A
    Nihon Geka Gakkai Zasshi; 2002 Jun; 103(6):472-5. PubMed ID: 12094698
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Preoperative peripheral blood human telomerase reverse transcriptase mRNA concentration is not a prognostic factor for resection of hepatocellular carcinoma.
    Kim YD; Hwang S; Lee YJ; Kim KH; Ahn CS; Park KM; Moon DB; Ha TY; Song GW; Jung DH; Park SR; Hong HN; Lee SG
    Hepatogastroenterology; 2012; 59(117):1512-5. PubMed ID: 22683968
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
    Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Sensitive and specific detection of circulating cancer cells in patients with hepatocellular carcinoma; detection of human telomerase reverse transcriptase messenger RNA after immunomagnetic separation.
    Waguri N; Suda T; Nomoto M; Kawai H; Mita Y; Kuroiwa T; Igarashi M; Kobayashi M; Fukuhara Y; Aoyagi Y
    Clin Cancer Res; 2003 Aug; 9(8):3004-11. PubMed ID: 12912949
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?
    Farinati F; Marino D; De Giorgio M; Baldan A; Cantarini M; Cursaro C; Rapaccini G; Del Poggio P; Di Nolfo MA; Benvegnù L; Zoli M; Borzio F; Bernardi M; Trevisani F
    Am J Gastroenterol; 2006 Mar; 101(3):524-32. PubMed ID: 16542289
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Detection of germ-cell tumor cells in the peripheral blood by nested reverse transcription-polymerase chain reaction for alpha-fetoprotein-messenger RNA and beta human chorionic gonadotropin-messenger RNA.
    Hautkappe AL; Lu M; Mueller H; Bex A; Harstrick A; Roggendorf M; Ruebben H
    Cancer Res; 2000 Jun; 60(12):3170-4. PubMed ID: 10866307
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
    Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG
    Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy.
    Ohguchi S; Nakatsukasa H; Higashi T; Ashida K; Nouso K; Ishizaki M; Hino N; Kobayashi Y; Uematsu S; Tsuji T
    Hepatology; 1998 Feb; 27(2):599-607. PubMed ID: 9462663
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Development of a novel assay to quantify serum human telomerase reverse transcriptase messenger RNA and its significance as a tumor marker for hepatocellular carcinoma.
    Miura N; Maruyama S; Oyama K; Horie Y; Kohno M; Noma E; Sakaguchi S; Nagashima M; Kudo M; Kishimoto Y; Kawasaki H; Hasegawa J; Shiota G
    Oncology; 2007; 72 Suppl 1():45-51. PubMed ID: 18087181
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Specific molecular markers in hepatocellular carcinoma.
    Yao DF; Dong ZZ; Yao M
    Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):241-7. PubMed ID: 17548245
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Human telomerase reverse transcriptase messenger RNA (TERT mRNA) as a tumour marker for early detection of hepatocellular carcinoma.
    El-Mazny A; Sayed M; Sharaf S
    Arab J Gastroenterol; 2014 Jun; 15(2):68-71. PubMed ID: 25097049
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Reduced expression of chemokine receptors on peripheral blood lymphocytes in patients with hepatocellular carcinoma.
    Liu Y; Poon RT; Feng X; Yu WC; Luk JM; Fan ST
    Am J Gastroenterol; 2004 Jun; 99(6):1111-21. PubMed ID: 15180734
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Alpha-fetoprotein gene polymorphisms and risk of HCC and cirrhosis.
    Suriapranata IM; Sudania WM; Tjong WY; Suciptan AA; Gani RA; Hasan I; Sanityoso A; Budihusodo U; Miskad UA; Akil F; Lelosutan SA; Martamala R; Yusuf I; Lesmana LA; Sulaiman A; Tai S
    Clin Chim Acta; 2010 Mar; 411(5-6):351-8. PubMed ID: 19968979
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
    Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G
    Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Analysis of CD4+ T-Cell responses to a novel alpha-fetoprotein-derived epitope in hepatocellular carcinoma patients.
    Alisa A; Ives A; Pathan AA; Navarrete CV; Williams R; Bertoletti A; Behboudi S
    Clin Cancer Res; 2005 Sep; 11(18):6686-94. PubMed ID: 16166448
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma].
    Moon JI; Kim JM; Jung GO; Chun JM; Choi GS; Park JB; Kwon CH; Kim SJ; Jo JW
    Korean J Hepatol; 2008 Jun; 14(2):185-96. PubMed ID: 18617766
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer.
    Louha M; Poussin K; Ganne N; Zylberberg H; Nalpas B; Nicolet J; Capron F; Soubrane O; Vons C; Pol S; Beaugrand M; Berthelot P; Franco D; Trinchet JC; Bréchot C; Paterlini P
    Hepatology; 1997 Oct; 26(4):998-1005. PubMed ID: 9328326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.